Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
Launched by EWHA WOMANS UNIVERSITY MOKDONG HOSPITAL · Feb 2, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a multi-center, prospective observational validation study. Patients aged 18 or above who are hospitalized at our hospital or who visited the outpatient clinic with arrhythmia symptoms (such as palpitation) after the clinical research approval will be enrolled. The normal sinus rhythm electrocardiogram (ECG) at the time of participation in the study is recorded and put into the artificial intelligence prediction algorithm. The result of risk stratification is blinded and will not be informed to both the research director and subjects. After applying wearable devices to the sub...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must be above 20 in age
- • Participants are patients with symptom of arrhythmia who visited outpatient clinic or who have been hospitalized
- Exclusion Criteria:
- • Excluding patients with cardiac implantable electronic device such as pacemakers, implantable defibrillators (ICD), or cardiac resynchronization therapy (CRT).
- • Excluding pregnant women and lactating women.
About Ewha Womans University Mokdong Hospital
Ewha Womans University Mokdong Hospital is a leading academic medical institution located in Seoul, South Korea, dedicated to advancing healthcare through innovative clinical research and education. Affiliated with Ewha Womans University, the hospital combines cutting-edge medical technology with a commitment to patient-centered care. It serves as a hub for clinical trials, focusing on a diverse range of therapeutic areas, and aims to enhance treatment outcomes and contribute to the global medical community. With a multidisciplinary team of experienced researchers and healthcare professionals, the hospital is committed to ethical standards and the highest quality of research practices, ensuring the integrity and reliability of its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gwangju, , Korea, Republic Of
Incheon, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Chungbuk, , Korea, Republic Of
Seoul, , Korea, Republic Of
Gyeonggi Do, , Korea, Republic Of
Patients applied
Trial Officials
Sumi Jung
Study Director
Ewha Womans University Mokdong Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials